March 2026
1. JOUSSET AB, Girlich D, Oueslati S, Birer A, et al
   In vivo selection of CMY-219 conferring resistance to ceftazidime-avibactam in an OXA-484-producing E. coli ST410.
   Antimicrob Agents Chemother. 2026;70:e0133525.
   

   >> Share

   
   
2. LEHMAN D, Hetzler AE, Friedrich T, Strouse MM, et al
   Variable chlorhexidine MICs across Klebsiella species from a single facility.
   Antimicrob Agents Chemother. 2026;70:e0143625.
   

   >> Share

   
   
3. BAI Y-M, Gao X-J, Yue C, Cai Z-P, et al
   Salmonella Stanley ST29 carrying IncHI2/ST3-bla(NDM-5) plasmid emerged in a 4-month-old infant with diarrhea.
   Antimicrob Agents Chemother. 2026;70:e0147125.
   

   >> Share

   
   
4. ROYER M, Cabanel N, Gutierrez A, Royer G, et al
   The mecillinam resistome in Klebsiella pneumoniae: how resistance to a one-target beta-lactam triggers a diversity of responses.
   Antimicrob Agents Chemother. 2026;70:e0120725.
   

   >> Share

   
   
5. WANG J, Zhu J, Wu W, Luo R, et al
   Clinical outcomes and safety of eravacycline in hematology: a multicenter, real-world study.
   Antimicrob Agents Chemother. 2026;70:e0128725.
   

   >> Share

   
   
6. DING R, Ma K, Zhang K, Liu J, et al
   Broxyquinoline enhances antibacterial activity of colistin and attenuates LPS-induced inflammation.
   Antimicrob Agents Chemother. 2026;70:e0139825.
   

   >> Share

   
   
7. GONZALEZ-DIAZ A, Pinto M, Cadenas-Jimenez I, Duarte S, et al
   First identification and molecular characterization of CTX-M-15 extended-spectrum beta-lactamase and OXA-9 beta-lactamase in Haemophilus influenzae in the Iberian Peninsula.
   Antimicrob Agents Chemother. 2026;70:e0164925.
   

   >> Share

   
   
8. YANG X, Ning W, Yuan Y, Hou X, et al
   Novel metabolic adaptation driven by glycoside hydrolase family 25 protein contributes to increasing trimethoprim-sulfamethoxazole resistance in clinical human Brucella melitensis isolates in China.
   Antimicrob Agents Chemother. 2026;70:e0128425.
   

   >> Share

   
   
9. PONTIKIS K, Karaiskos I, Sakagianni A, Mouloudi E, et al
   Comparative effectiveness of two antimicrobial regimens for the treatment of pan-drug-resistant Acinetobacter baumannii infections: results from the DESPAIR study.
   Antimicrob Agents Chemother. 2026;70:e0115425.
   

   >> Share

   
   
10. YIN T, Qu B, Zhang Q, Xu S, et al
    Pharmacokinetics, safety, and tolerability of HRS-8427, a novel anti-carbapenem-resistant cephalosporin, in healthy subjects.
    Antimicrob Agents Chemother. 2026 Mar 3:e0069425. doi: 10.1128/aac.00694.
    

    >> Share

    
    February 2026
11. CHEN J, Sun Z, Su J, Li P, et al
    Functional characterization of a novel class A carbapenemase CAE-1 in carbapenem-resistant Pseudomonas aeruginosa clinical isolates.
    Antimicrob Agents Chemother. 2026 Feb 23:e0136225. doi: 10.1128/aac.01362.
    

    >> Share

    
    
12. ZHANG R, Zhang C, Liu J, Kong X, et al
    Therapeutic effect of eravacycline against carbapenem-resistant hypervirulent Klebsiella pneumoniae in mouse models.
    Antimicrob Agents Chemother. 2026 Feb 23:e0123725. doi: 10.1128/aac.01237.
    

    >> Share

    
    
13. LI P, Xiao Y, Luo R, Zhang J, et al
    Comparative genomic, phenotypic, and clinical characterization of ST11-KL25 and ST11-KL64 hypervirulent carbapenem-resistant Klebsiella pneumoniae in a tertiary hospital, 2020-2023.
    Antimicrob Agents Chemother. 2026 Feb 19:e0108025. doi: 10.1128/aac.01080.
    

    >> Share

    
    
14. DELLIS C, Laros G, Georgiou K, Zhang L, et al
    Iotadentification of SQ109 analogs with enhanced antimicrobial activity against methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2026 Feb 18:e0154525. doi: 10.1128/aac.01545.
    

    >> Share

    
    
15. LEE Y-L, Wang W-Y, Huang Y-T, Ho M-W, et al
    In vitro activity of aztreonam-avibactam and distribution of carbapenemase genes in ceftazidime-avibactam-resistant carbapenem-resistant Enterobacterales: data from the global Antimicrobial Testing Leadership and Surveillance, 2019-2023.
    Antimicrob Agents Chemother. 2026 Feb 18:e0154925. doi: 10.1128/aac.01549.
    

    >> Share

    
    
16. MA D, Arya R, Knapick BA, Sadaka NM, et al
    Methicillin-resistant Staphylococcus aureus has phenotypic variation in mecA expression that alters antibiotic sensitivity.
    Antimicrob Agents Chemother. 2026 Feb 12:e0039625. doi: 10.1128/aac.00396.
    

    >> Share

    
    
17. NISHIHARA Y, Nakano R, Nakano A, Suzuki Y, et al
    Differences in beta-lactamase activity and carbapenem resistance among the Bacillus cereus group.
    Antimicrob Agents Chemother. 2026 Feb 9:e0130225. doi: 10.1128/aac.01302.
    

    >> Share

    
    
18. ZHENG X, You X, Liu Y, Wu B, et al
    Spatiotemporal dynamics and multiple driving factors of antimicrobial resistance in China during the COVID-19 pandemic (2019-2023): a provincial panel data analysis.
    Antimicrob Agents Chemother. 2026 Feb 9:e0160025. doi: 10.1128/aac.01600.
    

    >> Share

    
    
19. COLLINGS H, Stone M, Chrysostomou M, Hirst A, et al
    A systematic literature review and (network) meta-analysis of the effectiveness of ceftolozane/tazobactam versus aminoglycosides/polymyxins and ceftazidime/avibactam for treating adult patients with multidrug-resistant Pseudomonas aeruginosa infection
    Antimicrob Agents Chemother. 2026;70:e0073525.
    

    >> Share

    
    
20. MOHAMMAD S, Al Namer Y, Rahimeh W, Albalas M, et al
    Effectiveness and safety of meropenem-vaborbactam versus ceftazidime-avibactam in multidrug-resistant Gram-negative infections: a systematic review and meta-analysis with trial sequential analysis.
    Antimicrob Agents Chemother. 2026;70:e0154625.
    

    >> Share

    
    
21. OMACHI R, Imai K, Sato A, Tanaka M, et al
    Spread of dual-class drug-resistant Mycoplasma genitalium in Tokyo, Japan, 2023-2025.
    Antimicrob Agents Chemother. 2026;70:e0136725.
    

    >> Share

    
    
22. FAN M, Zhang Z, Liu X, Deng L, et al
    Phylogenetic diversification and fitness trade-offs of TetA variants in mediating eravacycline resistance in Klebsiella pneumoniae.
    Antimicrob Agents Chemother. 2026;70:e0067125.
    

    >> Share

    
    
23. FINGLETON C, Zeden MS, Bueno E, Cava F, et al
    Mutation of lipoprotein processing pathway gene lspA or inhibition of LspA activity by globomycin increases MRSA resistance to beta-lactam antibiotics.
    Antimicrob Agents Chemother. 2026;70:e0127625.
    

    >> Share

    
    
24. LIU Y, Cui P, Sun J, Ru S, et al
    A short antimicrobial peptides family demonstrates efficacy to infection via a multimodal mechanism of action.
    Antimicrob Agents Chemother. 2026;70:e0134325.
    

    >> Share

    
    
25. TIREAU B, Hamane S, Weber S, Benderdouche M, et al
    Comparison of gradient concentration strip and EUCAST methods for itraconazole and posaconazole MICs in Trichophyton indotineae.
    Antimicrob Agents Chemother. 2026;70:e0129325.
    

    >> Share

    
    
26. BAEZ-BARROSO G-A, Rodriguez-Coello A, Vazquez-Ucha JC, Lopez-Arguello S, et al
    Antibacterial activity of enmetazobactam against Acinetobacter spp.: a molecular dissection of mechanism of action and resistance determinants.
    Antimicrob Agents Chemother. 2026;70:e0120625.
    

    >> Share

    
    
27. ALHOTHALI MT, Seemann T, Andersson P, Sherry N, et al
    Rising burden of enterococcal bacteremia in Victoria, Australia: population-based incidence and antimicrobial resistance trends from three decades of surveillance.
    Antimicrob Agents Chemother. 2026 Feb 4:e0152625. doi: 10.1128/aac.01526.
    

    >> Share

    
    
28. SONG Y, Buil JB, Zoll J, Tehupeiory-Kooreman M, et al
    Characteristics of individual cyp51A SNPs and combinations thereof impacting the azole phenotype in TR(34)-mediated resistance genotypes of Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2026 Feb 3:e0152825. doi: 10.1128/aac.01528.
    

    >> Share

    
    January 2026
29. LEPAK A, Bhavnani SM, Castanheira M, Rubino CM, et al
    Evaluation of an in vivo pulmonary aspergillosis model for triazole susceptibility breakpoint development.
    Antimicrob Agents Chemother. 2026 Jan 30:e0164325. doi: 10.1128/aac.01643.
    

    >> Share

    
    
30. ARUN B, Sharma R, Valle Q, Bui NM, et al
    A genomics-informed mechanism-based pharmacokinetic/pharmacodynamic model of cefiderocol and ceftazidime/avibactam against carbapenem-resistant Achromobacter xylosoxidans.
    Antimicrob Agents Chemother. 2026 Jan 26:e0126325. doi: 10.1128/aac.01263.
    

    >> Share

    
    
31. SHARMA P, Dean D, Read TD
    Putative azithromycin resistance mutations in Chlamydia trachomatis are globally distributed but arose before azithromycin was discovered.
    Antimicrob Agents Chemother. 2026 Jan 26:e0170825. doi: 10.1128/aac.01708.
    

    >> Share

    
    
32. ZHOU W, Chen D, Dong X, Yang T, et al
    Emergence and genomic adaptation of the globally disseminated ST2250 lineage within the Staphylococcus aureus complex.
    Antimicrob Agents Chemother. 2026 Jan 26:e0162825. doi: 10.1128/aac.01628.
    

    >> Share

    
    
33. SHAO Y, Lan X, Zhang X, Wang L, et al
    fosZ, a novel plasmid-borne fosfomycin resistance gene in Pseudomonas species, especially carbapenem-resistant Pseudomonas aeruginosa isolates.
    Antimicrob Agents Chemother. 2026 Jan 14:e0075025. doi: 10.1128/aac.00750.
    

    >> Share

    
    
34. ANEKE CI, Shahegh SS, Freeman AF, Zerbe C, et al
    Beyond Fumigatus: a molecular portrait of clinical Aspergillus diversity, pathogenicity, and antifungal resistance.
    Antimicrob Agents Chemother. 2026 Jan 13:e0118425. doi: 10.1128/aac.01184.
    

    >> Share

    
    
35. CASTANHEIRA M, Kimbrough JH, Morgan GM, Karr M, et al
    Activity of aztreonam-avibactam, cefiderocol, and cefepime-taniborbactam against a global collection of genetically characterized metallo-beta-lactamase-producing Enterobacterales.
    Antimicrob Agents Chemother. 2026;70:e0084225.
    

    >> Share

    
    
36. LACKNER M, Toepfer S, Keniya MV, Lax C, et al
    The molecular basis of intrinsic resistance to azoles in Rhizopus arrhizus.
    Antimicrob Agents Chemother. 2026;70:e0133725.
    

    >> Share

    
    
37. VAN HELDEN SR, Bleick CR, Holger DJ, El Ghali A, et al
    Impact of Pseudomonas aeruginosa biofilm exopolysaccharide composition on bacteriophage and bacteriophage-antibiotic combination activity.
    Antimicrob Agents Chemother. 2026;70:e0092525.
    

    >> Share

    
    
38. VARIK V, Wang G, Kritikos G, Banzhaf M, et al
    Synergistic activity of rifampicin and polymyxin B against intracellular Gram-negative ESKAPE pathogens involves bacterial membrane alterations and enhanced oxidative damages.
    Antimicrob Agents Chemother. 2026;70:e0131925.
    

    >> Share

    
    December 2025
39. LLORENTE J, Sempere J, Llamosi M, Perez-Garcia C, et al
    Emergence of antibiotic-resistant pneumococcal serotypes causing invasive pneumococcal disease in children, Spain.
    Antimicrob Agents Chemother. 2025 Dec 31:e0153025. doi: 10.1128/aac.01530.
    

    >> Share

    
    
40. LUO J, Liu M, Ai W, Zheng X, et al
    Gtr9 mutation trades phage resistance for carbapenem sensitivity to potentiate phage-meropenem therapy against carbapenem-resistant Acinetobacter baumannii in vitro.
    Antimicrob Agents Chemother. 2025 Dec 30:e0135525. doi: 10.1128/aac.01355.
    

    >> Share

    
    
41. HINTERWIRTH A, Chen C, Yan D, Zhong L, et al
    Co-selection of genetic antibiotic resistance in Streptococcus pneumoniae after repeated azithromycin mass drug administrations in Niger.
    Antimicrob Agents Chemother. 2025 Dec 23:e0156225. doi: 10.1128/aac.01562.
    

    >> Share

    
    
42. PARK J, Choi S, Jeon YR, Kim L-H, et al
    Evaluation of clofazimine-bedaquiline combination as a candidate regimen for macrolide-resistant Mycobacterium avium complex infection.
    Antimicrob Agents Chemother. 2025 Dec 19:e0151125. doi: 10.1128/aac.01511.
    

    >> Share

    
    
43. MAHADEVAN R, Garcia E, Sharma R, Qiu H, et al
    A mechanism-based pharmacokinetic/pharmacodynamic analysis of polymyxin B-based combination therapy against carbapenem-resistant Klebsiella pneumoniae isolates with diverse phenotypic and genotypic resistance mechanisms.
    Antimicrob Agents Chemother. 2025 Dec 19:e0078225. doi: 10.1128/aac.00782.
    

    >> Share

    
    
44. LEONARD VHJ, Vidales DB, Taft BR, Hesse MJ, et al
    Identification and characterization of a novel inhibitor of influenza A virus that acts by blocking nucleoprotein oligomerization.
    Antimicrob Agents Chemother. 2025 Dec 19:e0114925. doi: 10.1128/aac.01149.
    

    >> Share

    
    
45. APPLEBACH E, Amburgey-Crovetti K, Bakotic WL, Adhikari TB, et al
    Prevalence and diversity of antifungal resistance in Fusarium isolates across clinical and agricultural settings in the United States.
    Antimicrob Agents Chemother. 2025;69:e0120825.
    

    >> Share

    
    
46. NODARI CS, Bai Q, Cayo R, Streling AP, et al
    ISAba1-mediated bla(ADC) disruption restores third-generation cephalosporin susceptibility in a clinical Acinetobacter baumannii isolate.
    Antimicrob Agents Chemother. 2025;69:e0070725.
    

    >> Share

    
    
47. CADENAS-JIMENEZ I, Gonzalez-Diaz A, Berbel D, Costa-Primo R, et al
    First report of a DIM-1-producing Pseudomonas aeruginosa in Spain: genomic characterization and resistance determinants.
    Antimicrob Agents Chemother. 2025;69:e0131125.
    

    >> Share

    
    
48. HESELPOTH RD, Euler CW, Fischetti VA
    Second-generation lysocins as therapeutics for treating Pseudomonas aeruginosa infections.
    Antimicrob Agents Chemother. 2025;69:e0131225.
    

    >> Share

    
    
49. HUSSEIN M, Crawford S, Baker M, Floyd H, et al
    Hyperforin potentiates polymyxin B against multidrug-resistant Gram-negative pathogens via membrane disruption, biofilm eradication, and oxidative stress.
    Antimicrob Agents Chemother. 2025;69:e0100725.
    

    >> Share

    
    
50. ALVARADO-OROSCO N, Gomis-Font MA, Sastre-Femenia MA, Ribera Ortiz S, et al
    First nationwide survey on Pseudomonas aeruginosa in Bolivia: susceptibility profiles, resistome, and genomic epidemiology.
    Antimicrob Agents Chemother. 2025;69:e0116325.
    

    >> Share

    
    
51. WANGCHINDA W, Wu JY, Abbo LM, Ackley R, et al
    Effectiveness of imipenem-relebactam for multidrug-resistant Pseudomonas aeruginosa in pneumonia and bloodstream infections in the United States (MIRAGE).
    Antimicrob Agents Chemother. 2025;69:e0132525.
    

    >> Share

    
    
52. FU Y, Zhang Y, Zhao J, Xie J, et al
    Emergence of co-resistance to imipenem/relebactam and ceftazidime/avibactam in clinical Klebsiella pneumoniae ST11 clone due to KPC-2 N132S and CTX-M-65 S130G/P167S substitutions.
    Antimicrob Agents Chemother. 2025;69:e0089125.
    

    >> Share

    
    
53. VANACHAYANGKUL P, Ruamsap N, Caridha D, Imerbsin R, et al
    Preclinical in vitro and in vivo evaluation of omadacycline against multidrug-resistant Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2025;69:e0093225.
    

    >> Share

    
    
54. KENT JE, Elane M, Leyn S, Zlamal J, et al
    Mutations in two-component signaling systems drive experimental evolution of tigecycline and colistin resistance in Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2025;69:e0080925.
    

    >> Share

    
    
55. COOPER K, Murthy K, Balzer T, Parkinson S, et al
    In vitro and in vivo characterization of Bisphosphocin Nu-3-a novel broad-spectrum antimicrobial compound with high potency against resistant pathogens.
    Antimicrob Agents Chemother. 2025;69:e0094825.
    

    >> Share

    
    
56. TAKEI K, Kanamori H, Sakata R, Ogawa M, et al
    High-risk clonal expansion of IMP-producing Enterobacter cloacae complex in regional Japanese healthcare settings.
    Antimicrob Agents Chemother. 2025;69:e0095325.
    

    >> Share

    
    
57. YOUSSEF EG, Gebremariam T, Gu Y, Patterson H, et al
    Efficacy assessments of EL219, a next-generation polyene antifungal, in immunosuppressed mice infected with drug-sensitive and drug-resistant Aspergillus isolates.
    Antimicrob Agents Chemother. 2025 Dec 5:e0140025. doi: 10.1128/aac.01400.
    

    >> Share

    
    November 2025
58. FUNK OG, Li J, Khan I, Cusumano JA, et al
    Ceftobiprole alone versus ampicillin-ceftriaxone against borderline-penicillin-resistant, ampicillin-susceptible, and vancomycin-resistant Enterococcus faecalis isolates.
    Antimicrob Agents Chemother. 2025 Nov 24:e0105025. doi: 10.1128/aac.01050.
    

    >> Share

    
    
59. LAVOIE T, Sierra T, Daffinee K, Pogue JM, et al
    Unlocking potentials: the impact of meropenem, meropenem-vaborbactam, and ceftazidime-avibactam in combating carbapenem-resistant Enterobacter cloacae.
    Antimicrob Agents Chemother. 2025 Nov 19:e0090625. doi: 10.1128/aac.00906.
    

    >> Share

    
    
60. HASHIMOTO Y, Dao DT, Kasuga I, Takemura T, et al
    Ongoing independent evolution of linezolid and vancomycin-resistance pELF-type linear plasmids across the One Health spectrum.
    Antimicrob Agents Chemother. 2025 Nov 18:e0116825. doi: 10.1128/aac.01168.
    

    >> Share

    
    
61. DARNELL RL, Knottenbelt MK, Rose OE, Cleary CSB, et al
    Prolonged exposure to teixobactin generates cross-tolerance to other cell wall-targeting antimicrobials in Enterococcus faecalis.
    Antimicrob Agents Chemother. 2025 Nov 18:e0062925. doi: 10.1128/aac.00629.
    

    >> Share

    
    
62. BEH JQ, Wick RR, Howden BP, Connor CH, et al
    Challenges and considerations for whole-genome-based antimicrobial resistance plasmid investigations.
    Antimicrob Agents Chemother. 2025 Nov 11:e0109725. doi: 10.1128/aac.01097.
    

    >> Share

    
    
63. FINDLAY J, Nordmann P, Jayol A, Seth-Smith HMB, et al
    Carbapenem resistance in a Klebsiella quasipneumoniae isolate resulting from production of CTX-M-33 and OmpK36 porin deficiency.
    Antimicrob Agents Chemother. 2025 Nov 6:e0121425. doi: 10.1128/aac.01214.
    

    >> Share

    
    
64. HE G, Zeng S, Banki LT, Zhou W, et al
    Clinical emergence of inducible macrolide resistance mediated by acquired erm(41) C28T mutation in Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2025 Nov 6:e0115325. doi: 10.1128/aac.01153.
    

    >> Share

    
    
65. XUE R, Gao S, de Hoog S, van Diepeningen A, et al
    Olorofim activity against multidrug-resistant Fusarium unveils intra-species and inter-species variability.
    Antimicrob Agents Chemother. 2025;69:e0096125.
    

    >> Share

    
    
66. WIEDERHOLD NP
    Case Commentary: Successful use of olorofim for the treatment of multi-drug-resistant Lomentospora prolificans infection in a child.
    Antimicrob Agents Chemother. 2025;69:e0107225.
    

    >> Share

    
    
67. MASSIC L, Doorley LA, Jones SJ, Richardson I, et al
    Acquired amphotericin B resistance attributed to a mutated ERG3 in Candidozyma auris.
    Antimicrob Agents Chemother. 2025;69:e0060125.
    

    >> Share

    
    
68. RAMIREZ D, Ramirez DM, Arora R, Arthur G, et al
    Noncytotoxic polymyxin derivatives enhance antibiotic action against multidrug-resistant Gram-negative bacteria.
    Antimicrob Agents Chemother. 2025;69:e0071225.
    

    >> Share

    
    
69. KUNZ COYNE AJ, Gray R, May E, Curry H, et al
    Molecular and pharmacodynamic insights into beta-lactam therapy for high-inoculum Enterobacter cloacae complex infections.
    Antimicrob Agents Chemother. 2025;69:e0117025.
    

    >> Share

    
    
70. WANG C, Feng Y, Zong Z
    Colistin heteroresistance in Enterobacter due to base heterozygosity at certain phoP and phoQ locations.
    Antimicrob Agents Chemother. 2025;69:e0071325.
    

    >> Share

    
    
71. LODISE TP, Min J, Nathanson BH, Yucel E, et al
    Comparison of early treatment with ceftolozane/tazobactam versus polymyxin-based therapy of pneumonia due to MDR Pseudomonas aeruginosa (PUMA).
    Antimicrob Agents Chemother. 2025;69:e0056925.
    

    >> Share

    
    
72. MORAN-BARRIO J, Giacone L, Brambilla L, Fabbri C, et al
    The lipoprotein biosynthesis pathway: key to OXA-mediated carbapenem resistance in Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2025 Nov 4:e0109925. doi: 10.1128/aac.01099.
    

    >> Share

    
    
73. MOHAMAD M, Hurst MM, Elkrewi E, Randall CP, et al
    Nature of bacitracin resistance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2025 Nov 4:e0087525. doi: 10.1128/aac.00875.
    

    >> Share

    
    October 2025
74. HODBERT E, Lemenand O, Thibaut S, Coeffic T, et al
    Exploring multidrug resistance patterns in community-acquired Escherichia coli urinary tract infections with machine learning.
    Antimicrob Agents Chemother. 2025 Oct 31:e0042225. doi: 10.1128/aac.00422.
    

    >> Share

    
    
75. SUN L, Lei T, Liu Y, Lu S, et al
    In vivo development of elevated linezolid resistance mediated by a deletion in ribosomal protein L3 in clinical Enterococcus faecium.
    Antimicrob Agents Chemother. 2025 Oct 28:e0087125. doi: 10.1128/aac.00871.
    

    >> Share

    
    
76. MARCH VFA, Zwyer M, Loiseau C, Brites D, et al
    Variability in intrinsic drug tolerance in Mycobacterium tuberculosis corresponds with phylogenetic lineage.
    Antimicrob Agents Chemother. 2025 Oct 21:e0099625. doi: 10.1128/aac.00996.
    

    >> Share

    
    
77. SHAW S, Pragasam AK, Chowdhury G, Samanta P, et al
    Genomic portrayal of emerging carbapenem-resistant El Tor variant Vibrio cholerae O1.
    Antimicrob Agents Chemother. 2025 Oct 17:e0074025. doi: 10.1128/aac.00740.
    

    >> Share

    
    
78. FRIAES A, Mamede R, Santos B, Marrao G, et al
    Increase of macrolide resistance among Streptococcus pyogenes pharyngitis driven by a mef(A)-msr(D)/emm2-ST55 lineage in Portugal (2014-2019).
    Antimicrob Agents Chemother. 2025 Oct 10:e0096825. doi: 10.1128/aac.00968.
    

    >> Share

    
    
79. ALVARADO CASAS ML, Triana Diaz JA, Montilla-Escudero E, Prada Cardozo DA, et al
    Genomic epidemiology of Colombian resistant Candida auris isolates.
    Antimicrob Agents Chemother. 2025 Oct 7:e0072525. doi: 10.1128/aac.00725.
    

    >> Share

    
    
80. DONG X, Xiang Y, Li Y, Zhang Y, et al
    Lineage-specific evolution and resistance-virulence divergence in Klebsiella pneumoniae ST268: a global population genomic analysis.
    Antimicrob Agents Chemother. 2025;69:e0070325.
    

    >> Share

    
    
81. RAKA V, Jangra M, Kaur P, Dadwal R, et al
    Preclinical evaluation of tridecaptin M: in vitro and in vivo efficacy against colistin-resistant Gram-negative bacterial pathogens and pharmacokinetics.
    Antimicrob Agents Chemother. 2025;69:e0108325.
    

    >> Share

    
    
82. ALARCON RIOS AC, Zwep LB, Vriesendorp B, Knibbe CAJ, et al
    Colistin resistance dynamics in Pseudomonas aeruginosa under biofilm and planktonic growth.
    Antimicrob Agents Chemother. 2025;69:e0042125.
    

    >> Share

    
    
83. WAN T-W, Shintani M, Kojima KK, Moriguchi N, et al
    Transposition of Tn552-II (a Tn552 derivative) to the conjugative pCtra plasmid family in pediatric multidrug-resistant community-associated MRSA.
    Antimicrob Agents Chemother. 2025;69:e0064725.
    

    >> Share

    
    September 2025
84. VENA A, Bartalucci C, Muccio M, Tiseo G, et al
    Comparative effectiveness of echinocandins and liposomal amphotericin B for fluconazole-resistant Candida parapsilosis bloodstream infections.
    Antimicrob Agents Chemother. 2025 Sep 30:e0035525. doi: 10.1128/aac.00355.
    

    >> Share

    
    
85. SHINOHARA T, Wada A, Abe M, Oiki S, et al
    A zinc-chelating cyclic alkyl polyamine compound is efficient and safe in a murine model of multidrug-resistant Candida auris infection.
    Antimicrob Agents Chemother. 2025 Sep 26:e0085625. doi: 10.1128/aac.00856.
    

    >> Share

    
    
86. PETERSEN S, Diricks M, Utpatel C, Schulenburg H, et al
    Evolution of beta-lactam resistance causes fitness reductions and several cases of collateral sensitivities in the human pathogen Haemophilus influenzae.
    Antimicrob Agents Chemother. 2025 Sep 22:e0057625. doi: 10.1128/aac.00576.
    

    >> Share

    
    
87. ZENG Q, Huang H, Lu J, Wu L, et al
    Comparison of different colistin sulfate regimens for carbapenem-resistant gram-negative bacteria pneumonia in neurocritical care patients: a retrospective cohort study.
    Antimicrob Agents Chemother. 2025 Sep 22:e0064425. doi: 10.1128/aac.00644.
    

    >> Share

    
    
88. SICELOFF AT, Ohta N, Norman KN, Loneragan GH, et al
    Correction for Siceloff et al., "Antimicrobial Resistance Hidden within Multiserovar Salmonella Populations".
    Antimicrob Agents Chemother. 2025 Sep 18:e0092625. doi: 10.1128/aac.00926.
    

    >> Share

    
    
89. MARTIN-VICENTE A, Nywening AV, Xie J, Thorn HI, et al
    Genetic analysis of common triazole resistance mechanisms in a collection of Aspergillus lentulus clinical isolates from the United States.
    Antimicrob Agents Chemother. 2025 Sep 12:e0069025. doi: 10.1128/aac.00690.
    

    >> Share

    
    
90. TURNER AM, Kinsella P, Miller WR, Carter GP, et al
    Therapeutic approach to difficult-to-treat multidrug-resistant enterococcal infections.
    Antimicrob Agents Chemother. 2025 Sep 11:e0106024. doi: 10.1128/aac.01060.
    

    >> Share

    
    
91. SCANGARELLA-OMAN NE, Butler DL, Breton J, Brown D, et al
    Efficacy and in vitro activity of gepotidacin against bacterial uropathogens, including subsets with molecularly characterized resistance mechanisms and genotypes/epidemiological clones, in females with uncomplicated urinary tract infections: results
    Antimicrob Agents Chemother. 2025 Sep 9:e0163924. doi: 10.1128/aac.01639.
    

    >> Share

    
    
92. SCANGARELLA-OMAN NE, Butler DL, Breton J, Brown D, et al
    Efficacy and in vitro activity of gepotidacin against bacterial uropathogens, including drug-resistant phenotypes, in females with uncomplicated urinary tract infections: results from two global, pivotal, phase 3 trials (EAGLE-2 and EAGLE-3).
    Antimicrob Agents Chemother. 2025 Sep 9:e0164024. doi: 10.1128/aac.01640.
    

    >> Share

    
    
93. YU H, Peng W, Li H, Zhang Y, et al
    Agricultural propiconazole residues promote triazole cross-resistance in Cryptococcus neoformans through ERG11 and efflux pump overexpression.
    Antimicrob Agents Chemother. 2025;69:e0076525.
    

    >> Share

    
    
94. CASTILLO-RAMIREZ S, Aguilar-Vera A, Kumar A, Evans B, et al
    Acinetobacter baumannii: much more than a human pathogen.
    Antimicrob Agents Chemother. 2025;69:e0080125.
    

    >> Share

    
    
95. WANG C, Huang H, Valera L, Parcella K, et al
    Preclinical virology profiles of the HIV-1 capsid inhibitors VH4004280 and VH4011499.
    Antimicrob Agents Chemother. 2025 Sep 3:e0030925. doi: 10.1128/aac.00309.
    

    >> Share

    
    August 2025
96. LAI Y-T, Dingens AS, DeMouth M, Helmold Hait S, et al
    Fostemsavir analog BMS-818251 has enhanced viral neutralization potency and similar escape mutation profile.
    Antimicrob Agents Chemother. 2025 Aug 27:e0191024. doi: 10.1128/aac.01910.
    

    >> Share

    
    
97. REITLER P, DeJarnette CA, Kumar R, Tucker KM, et al
    A screen to identify antifungal antagonists reveals a variety of pharmacotherapies that induce echinocandin tolerance in Candida albicans.
    Antimicrob Agents Chemother. 2025 Aug 18:e0048425. doi: 10.1128/aac.00484.
    

    >> Share

    
    
98. BARKER KS, Santana DJ, Zhang Q, Peters TL, et al
    Mutations in TAC1B drive increased CDR1 and MDR1 expression and azole resistance in Candida auris.
    Antimicrob Agents Chemother. 2025 Aug 18:e0030025. doi: 10.1128/aac.00300.
    

    >> Share

    
    
99. BUYUKYANBOLU E, Argotsinger J, Beck ET, Chamberland RR, et al
    Activity of ampicillin-sulbactam, sulbactam-durlobactam, and comparators against Acinetobacter baumannii-calcoaceticus complex strains isolated from respiratory and bloodstream sources: results from ACNBio study.
    Antimicrob Agents Chemother. 2025;69:e0037925.
    

    >> Share

    
    
100. KUBIN CJ, Garzia C, Uhlemann A-C
     Acinetobacter baumannii treatment strategies: a review of therapeutic challenges and considerations.
     Antimicrob Agents Chemother. 2025;69:e0106324.
     

     >> Share

     
     
101. SARAL SARIYER A, Leus IV, Tambat R, Farjana M, et al
     Mutations in the proximal binding site and F-loop of AdeJ confer resistance to efflux pump inhibitors.
     Antimicrob Agents Chemother. 2025;69:e0009025.
     

     >> Share

     
     
102. MELETIADIS J, Jorgensen KM, Astvad KMT, Abou-Chakra N, et al
     EUCAST olorofim MICs for 3,550 Danish mold and dermatophyte isolates from 2020 to 2023.
     Antimicrob Agents Chemother. 2025;69:e0035325.
     

     >> Share

     
     
103. ZHANG W, Peng K, Liu M, Luo X, et al
     Detection of SXT/R391 integrative conjugative elements carrying tigecycline resistance genes in Shewanella spp. isolated from retail seafood.
     Antimicrob Agents Chemother. 2025;69:e0174224.
     

     >> Share

     
     
104. VAHEDI-SHAHANDASHTI R, Hofer I, Leighton H, Fothergill J, et al
     The impact of respiratory tract mimicking media on antifungal susceptibility testing.
     Antimicrob Agents Chemother. 2025;69:e0022525.
     

     >> Share

     
     
105. OJHA S, Chatterjee P, Beuria TK
     Inhibition of efflux pumps by FDA-approved drugs oxiconazole and sertaconazole restores antibiotic susceptibility in multidrug-resistant S. aureus.
     Antimicrob Agents Chemother. 2025 Aug 4:e0032025. doi: 10.1128/aac.00320.
     

     >> Share

     
     July 2025
106. VIDUCIC D, Obranic S, Matovina M, Babic F, et al
     Biological cost of aminoglycoside resistance Arm/Kam 16S rRNA methyltransferases from natural antibiotic producers and clinical pathogens.
     Antimicrob Agents Chemother. 2025 Jul 31:e0074225. doi: 10.1128/aac.00742.
     

     >> Share

     
     
107. NONG L, Liu X, Wang X, de Leeuw W, et al
     Driving factors for beta-lactam resistance gene amplification during de novo resistance evolution in E. coli.
     Antimicrob Agents Chemother. 2025 Jul 23:e0044125. doi: 10.1128/aac.00441.
     

     >> Share

     
     
108. FANG Y, Song M, Zhang Y, Wu Z, et al
     Evolution of XDR Pseudomonas aeruginosa ST463 strains with two plasmids harboring multiple antimicrobial resistance genes.
     Antimicrob Agents Chemother. 2025 Jul 23:e0169724. doi: 10.1128/aac.01697.
     

     >> Share

     
     
109. YAMADA AY, de Souza AR, Madalosso G, de Assis DB, et al
     Emergence of carbapenem-resistant Acinetobacter baumannii clonal complex 2 in multiple hospitals in Sao Paulo state, Brazil.
     Antimicrob Agents Chemother. 2025 Jul 23:e0186524. doi: 10.1128/aac.01865.
     

     >> Share

     
     
110. WU Y, Dai Y, Lu H, Jiang X, et al
     Osh2 mediates Candida species resistance to miltefosine by regulating zymosterol accumulation.
     Antimicrob Agents Chemother. 2025 Jul 23:e0042725. doi: 10.1128/aac.00427.
     

     >> Share

     
     
111. BARKER KS, Patterson HP, Morschhauser J, Cuomo CA, et al
     Mutations in transcription factors that confer fluconazole resistance also confer reduced susceptibility to manogepix in Candida auris (Candidozyma auris), Candida albicans, Candida parapsilosis, and Candida glabrata (Nakaseomyces glabratus).
     Antimicrob Agents Chemother. 2025 Jul 23:e0068025. doi: 10.1128/aac.00680.
     

     >> Share

     
     
112. TUANYOK A, Nakajima C, Noll T, Khan MSR, et al
     Genomic insights into ceftazidime resistance in Burkholderia pseudomallei: discovery of A172T mutation and palindromic GC-rich repeat sequences facilitating penA duplication and amplification.
     Antimicrob Agents Chemother. 2025 Jul 21:e0022025. doi: 10.1128/aac.00220.
     

     >> Share

     
     
113. BELLO-LOPEZ E, Kawabata A, Cantero J, Mendoza S, et al
     Genomic epidemiology reveals antibiotic resistance transfer and polyclonal dissemination of Acinetobacter baumannii in a Paraguayan hospital.
     Antimicrob Agents Chemother. 2025 Jul 8:e0007725. doi: 10.1128/aac.00077.
     

     >> Share

     
     
114. GATTI M, Rinaldi M, Cojutti PG, Bonazzetti C, et al
     A pre-post quasi-experimental study of antimicrobial stewardship exploring the impact of a multidisciplinary approach aimed at attaining an aggressive joint pharmacokinetic/pharmacodynamic target with ceftazidime/avibactam on treatment outcome of KPC-
     Antimicrob Agents Chemother. 2025;69:e0048825.
     

     >> Share

     
     
115. HOU Y, Pi R, Jia J, Wu Z, et al
     Limited predictive power of known resistance genes for phenotypic drug resistance in clinical Mycobacterium abscessus complex from Beijing in China.
     Antimicrob Agents Chemother. 2025;69:e0184724.
     

     >> Share

     
     
116. FERRREIRA CDO, Leturiondo AL, Dos Santos CG, da Silva JB, et al
     Classic and new candidate markers for drug resistance in a large cohort of leprosy patients from the Amazon state, Brazil.
     Antimicrob Agents Chemother. 2025;69:e0155024.
     

     >> Share

     
     
117. OUTEDA-GARCIA M, Garcia-Pose A, Guijarro-Sanchez P, Rodriguez-Coello A, et al
     The novel polymyxin analogue SPR206 exhibits higher activity than colistin against both colistin-susceptible and colistin-resistant strains of Acinetobacter baumannii.
     Antimicrob Agents Chemother. 2025;69:e0194024.
     

     >> Share

     
     
118. RAJAKANI SG, Xavier BB, Nguyen NM, Lin Q, et al
     Characterization of genome-wide transpositions induced by colistin exposure in multi-drug-resistant Klebsiella pneumoniae.
     Antimicrob Agents Chemother. 2025;69:e0157424.
     

     >> Share

     
     
119. VAHEDI-SHAHANDASHTI R, Moroder E, Lass-Florl C
     Candida parapsilosis and echinocandins: should the clinical laboratory drop anidulafungin Etest from the susceptibility testing panel?
     Antimicrob Agents Chemother. 2025 Jul 1:e0024125. doi: 10.1128/aac.00241.
     

     >> Share

     
     June 2025
120. ANDREANI J, Truffot A, Tilloy V, Jardin H, et al
     Long-range PCRs and next-generation sequencing to detect cytomegalovirus drug resistance-associated mutations.
     Antimicrob Agents Chemother. 2025 Jun 25:e0014125. doi: 10.1128/aac.00141.
     

     >> Share

     
     
121. AI Q, Wang S, Chen Z, Zheng S, et al
     Synergistic antibacterial activity and prevention of drug resistance of daptomycin combined with fosfomycin against methicillin-resistant Staphylococcus aureus.
     Antimicrob Agents Chemother. 2025 Jun 18:e0160924. doi: 10.1128/aac.01609.
     

     >> Share

     
     
122. LEUS IV, Zgurskaya HI
     No two are alike: on the role of Klebsiella pneumoniae permeability barriers in antibiotic susceptibility and persistence.
     Antimicrob Agents Chemother. 2025 Jun 17:e0008525. doi: 10.1128/aac.00085.
     

     >> Share

     
     
123. MEEKES LM, Heikema AP, Tompa M, Astorga Alsina AL, et al
     Proteogenomic analysis demonstrates increased bla(OXA-48) copy numbers and OmpK36 loss as contributors to carbapenem resistance in Klebsiella pneumoniae.
     Antimicrob Agents Chemother. 2025 Jun 13:e0010725. doi: 10.1128/aac.00107.
     

     >> Share

     
     
124. WANG K, Xu J, Lu X, Yin P, et al
     Two novel trimethoprim resistance genes, dfra50 and dfra51, identified in phage-plasmids.
     Antimicrob Agents Chemother. 2025 Jun 12:e0169524. doi: 10.1128/aac.01695.
     

     >> Share

     
     
125. WAITES JT, Crabb DM, Ratliff AE, Waites KB, et al
     Antimicrobial susceptibility and genetic mechanisms of resistance of Ureaplasma isolates in North America between 2012 and 2023.
     Antimicrob Agents Chemother. 2025;69:e0186824.
     

     >> Share

     
     
126. MATEO-VARGAS MA, Rodriguez-Pallares S, Arca-Suarez J, Lopez-Cerero L, et al
     Emergence of KPC-8-producing K. pneumoniae infection without prior exposure to ceftazidime/avibactam: the threat of de novo infections by ceftazidime/avibactam-resistant KPC variants.
     Antimicrob Agents Chemother. 2025;69:e0149424.
     

     >> Share

     
     May 2025
127. LIU X, Qu X, Zhang R, Zhang Y, et al
     Synergistic combination of next-generation polymyxin MRX-8 and meropenem against carbapenem-resistant A. baumannii.
     Antimicrob Agents Chemother. 2025 May 27:e0191224. doi: 10.1128/aac.01912.
     

     >> Share

     
     
128. XIE L, Li J, Peng Q, Liu X, et al
     Contribution of RND superfamily multidrug efflux pumps AdeABC, AdeFGH, and AdeIJK to antimicrobial resistance and virulence factors in multidrug-resistant Acinetobacter baumannii AYE.
     Antimicrob Agents Chemother. 2025 May 23:e0185824. doi: 10.1128/aac.01858.
     

     >> Share

     
     
129. NELSON ME, Little JL, Kristich CJ
     Correction for Nelson et al., "Pbp4 provides transpeptidase activity to the FtsW-PbpB peptidoglycan synthase to drive cephalosporin resistance in Enterococcus faecalis".
     Antimicrob Agents Chemother. 2025 May 20:e0059425. doi: 10.1128/aac.00594.
     

     >> Share

     
     
130. LI X, Zhou L, Wang D, Wu Q, et al
     Population pharmacokinetics study on nebulized and intravenous administration of polymyxin B in patients with pneumonia caused by multidrug-resistant gram-negative bacteria.
     Antimicrob Agents Chemother. 2025;69:e0004425.
     

     >> Share

     
     
131. HIKAL AF, Zhao S, Foley S, Khan AA, et al
     The newly identified grdA gene confers high-level plazomicin resistance in Salmonella enterica serovars.
     Antimicrob Agents Chemother. 2025;69:e0160624.
     

     >> Share

     
     
132. LACROIX M, Moreau J, Zampaloni C, Bissantz C, et al
     In vitro pharmacokinetic/pharmacodynamic modeling of the effect of mucin on polymyxin B activity against Acinetobacter baumannii.
     Antimicrob Agents Chemother. 2025;69:e0153524.
     

     >> Share

     
     April 2025
133. LEE J, Lee I, Lee K-B, Lee SS, et al
     Comparative effectiveness and safety of colistin-based versus high-dose ampicillin/sulbactam-based combination therapy for nosocomial pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
     Antimicrob Agents Chemother. 2025 Apr 23:e0188024. doi: 10.1128/aac.01880.
     

     >> Share

     
     
134. ZHANG Y, Zhou B, Kong J, Hu P, et al
     Prevalence and characteristics of tigecycline- and carbapenem-resistant adeN-truncated Acinetobacter baumannii: a genomic epidemiological analysis.
     Antimicrob Agents Chemother. 2025 Apr 23:e0184324. doi: 10.1128/aac.01843.
     

     >> Share

     
     
135. SZEL V, Phelan JE, Georghiou SB, Dolinger DL, et al
     The ahpC c-54t compensatory mutation is not always a valid surrogate for isoniazid resistance in Mycobacterium tuberculosis.
     Antimicrob Agents Chemother. 2025 Apr 22:e0026525. doi: 10.1128/aac.00265.
     

     >> Share

     
     
136. SHERRY NL, Lee JYH, Giulieri SG, Connor CH, et al
     Genomics for antimicrobial resistance-progress and future directions.
     Antimicrob Agents Chemother. 2025 Apr 14:e0108224. doi: 10.1128/aac.01082.
     

     >> Share

     
     
137. ARDIZZONI E, Mulders W, De Diego Fuertes M, Hayrapetyan A, et al
     Phenotypic and genotypic resistance to bedaquiline in patients with multi-drug-resistant tuberculosis-experiences from Armenia.
     Antimicrob Agents Chemother. 2025 Apr 9:e0183924. doi: 10.1128/aac.01839.
     

     >> Share

     
     
138. HUANG H, Chen Y, Zhang L, Wan P, et al
     Identification and characterization of a novel major facilitator superfamily (MFS) efflux pump conferring multidrug resistance in Staphylococcus aureus and Staphylococcus epidermidis.
     Antimicrob Agents Chemother. 2025 Apr 7:e0173924. doi: 10.1128/aac.01739.
     

     >> Share

     
     
139. SASTRE-FEMENIA MA, Gomis-Font MA, Oliver A
     Mutant prevention concentrations and phenotypic and genomic profiling of first-step resistance mechanisms to classical and novel beta-lactams in Pseudomonas aeruginosa.
     Antimicrob Agents Chemother. 2025;69:e0194224.
     

     >> Share

     
     
140. SADER HS, Castanheira M, Arends SJR, Doyle TB, et al
     Antimicrobial susceptibility of Stenotrophomonas maltophilia from United States medical centers (2019-2023).
     Antimicrob Agents Chemother. 2025;69:e0012425.
     

     >> Share

     
     
141. SAMPER-CATIVIELA C, Torre-Fuentes L, Dieguez-Roda B, Maex M, et al
     Molecular epidemiology of Salmonella Enteritidis in humans and animals in Spain.
     Antimicrob Agents Chemother. 2025;69:e0073824.
     

     >> Share

     
     
142. MA Y, Pirolo M, Giarratana L, Leth Nielsen K, et al
     Chromosomal genes modulating fosfomycin susceptibility in uropathogenic Escherichia coli: a genome-wide analysis.
     Antimicrob Agents Chemother. 2025;69:e0141724.
     

     >> Share

     
     
143. PROENCA AM, Rang CU, Chao L
     A link between aging and persistence.
     Antimicrob Agents Chemother. 2025;69:e0131324.
     

     >> Share

     
     
144. HUSSAIN A, Bhando T, Casius A, Gupta R, et al
     Deciphering meropenem persistence in Acinetobacter baumannii facilitates discovery of anti-persister activity of thymol.
     Antimicrob Agents Chemother. 2025;69:e0138124.
     

     >> Share

     
     March 2025
145. SONG Y, An Q, Chen S, Dai H, et al
     Antimicrobial resistance of pet-derived bacteria in China, 2000-2020.
     Antimicrob Agents Chemother. 2025 Mar 26:e0165724. doi: 10.1128/aac.01657.
     

     >> Share

     
     
146. PEROUTKA-BIGUS N, Brooks EJ, Ramey ME, D'Erasmo H, et al
     Contribution of front-line, standard-of-care drugs to bactericidal responses, resistance emergence, and cure in murine models of easy- or hard-to-treat tuberculosis disease.
     Antimicrob Agents Chemother. 2025 Mar 26:e0190124. doi: 10.1128/aac.01901.
     

     >> Share

     
     
147. HUANG H, Wan P, Chen Y, Luo X, et al
     Phenotypic and genetic stepwise changes in Staphylococcus aureus during in vitro adaptive laboratory evolution under the selective pressure of tigecycline.
     Antimicrob Agents Chemother. 2025 Mar 26:e0007225. doi: 10.1128/aac.00072.
     

     >> Share

     
     
148. KIM M-J, Zarnowski R, Jones R, Nett JE, et al
     Vesicle inhibition reduces Candida biofilm resistance.
     Antimicrob Agents Chemother. 2025 Mar 26:e0004525. doi: 10.1128/aac.00045.
     

     >> Share

     
     
149. MAHE A, Verneuil N, Coupri D, Hartke A, et al
     D-alanylation of lipoteichoic acids inhibitor provides anti-virulence and anti-resistance effects against methicillin-resistant Staphylococcus epidermidis.
     Antimicrob Agents Chemother. 2025 Mar 21:e0182224. doi: 10.1128/aac.01822.
     

     >> Share

     
     
150. MUNITA JM, Tamma PD
     Fighting resistance with redundancy: a path forward for treating antimicrobial-resistant infections?
     Antimicrob Agents Chemother. 2025 Mar 14:e0012125. doi: 10.1128/aac.00121.
     

     >> Share

     
     
151. PETERSEN ME, Khamas AB, Ostergaard LJ, Jorgensen NP, et al
     Combination therapy delays antimicrobial resistance after adaptive laboratory evolution of Staphylococcus aureus.
     Antimicrob Agents Chemother. 2025 Mar 14:e0148324. doi: 10.1128/aac.01483.
     

     >> Share

     
     
152. ZHAO L, Li C, Wang M, Zhou M, et al
     Potent antiviral activity of simnotrelvir against key epidemic SARS-CoV-2 variants with a high resistance barrier.
     Antimicrob Agents Chemother. 2025 Mar 10:e0155624. doi: 10.1128/aac.01556.
     

     >> Share

     
     
153. YU Z, Hu H, Liu X, Liu J, et al
     Clinical outcomes and pharmacokinetics/pharmacodynamics of intravenous polymyxin B treatment for various site carbapenem-resistant gram-negative bacterial infections: a prospective observational multicenter study.
     Antimicrob Agents Chemother. 2025 Mar 6:e0185924. doi: 10.1128/aac.01859.
     

     >> Share

     
     
154. LEMAITRE N, Dewitte A, Rakotomanimana F, Gooden D, et al
     Assessing the threat of Yersinia pestis harboring a multi-resistant IncC plasmid and the efficacy of an antibiotic targeting LpxC.
     Antimicrob Agents Chemother. 2025;69:e0149724.
     

     >> Share

     
     
155. ROJAS LJ, Nielsen TB, Pantapalangkoor P, Taracila MA, et al
     Restoring cefepime activity against multidrug-resistant KPC-producing Klebsiella pneumoniae by combination with boronic acid inhibitors, MB076 and S02030.
     Antimicrob Agents Chemother. 2025;69:e0096424.
     

     >> Share

     
     
156. DORAZIO AJ, Kline EG, Squires KM, Pogue JM, et al
     Restoring ceftolozane susceptibility: a role for diazabicyclooctane beta-lactamase inhibitors?
     Antimicrob Agents Chemother. 2025;69:e0154324.
     

     >> Share

     
     
157. CORNISTEIN W, Balasini C, Nuccetelli Y, Rodriguez VM, et al
     Prevalence and mortality associated with multidrug-resistant infections in adult intensive care units in Argentina (PREV-AR).
     Antimicrob Agents Chemother. 2025;69:e0142624.
     

     >> Share

     
     February 2025
158. YU H, Wang L, Liu X, Zheng J, et al
     Mechanistic insights into the multitarget synergistic efficacy of farrerol and beta-lactam antibiotics in combating methicillin-resistant Staphylococcus aureus.
     Antimicrob Agents Chemother. 2025 Feb 28:e0155124. doi: 10.1128/aac.01551.
     

     >> Share

     
     
159. FU S-Y, Chen X-Z, Yi P-C, Gao J, et al
     Optimizing phage therapy for carbapenem-resistant Enterobacter cloacae bacteremia: insights into dose and timing.
     Antimicrob Agents Chemother. 2025 Feb 26:e0168324. doi: 10.1128/aac.01683.
     

     >> Share

     
     
160. FILE TM JR, Ramirez JA, Wilde AM
     New Perspectives on Antimicrobial Agents: Omadacycline for community-acquired pneumonia, skin and soft tissue infections, and nontuberculous mycobacteria (focus on M. abscessus).
     Antimicrob Agents Chemother. 2025;69:e0108724.
     

     >> Share

     
     
161. BONCOMPAGNI SR, Riccobono E, Cusi MG, Di Pilato V, et al
     Evidence of dissemination of a clc-type integrative and conjugative element to Stenotrophomonas maltophilia, mediating acquisition of sul1 and other resistance determinants.
     Antimicrob Agents Chemother. 2025;69:e0155424.
     

     >> Share

     
     
162. ROSON-CALERO N, Gomis Font MA, Ruiz-Soriano A, Just-Baringo X, et al
     In vitro potentiation of tetracyclines in Pseudomonas aeruginosa by RW01, a new cyclic peptide.
     Antimicrob Agents Chemother. 2025;69:e0145924.
     

     >> Share

     
     
163. RODRIGUEZ L, Lee HW, Li J, Martin R, et al
     SARS-CoV-2 resistance analyses from the Phase 3 PINETREE study of remdesivir treatment in nonhospitalized participants.
     Antimicrob Agents Chemother. 2025;69:e0123824.
     

     >> Share

     
     
164. GHEBREKRISTOS Y, Ahmed A, Beylis N, Singh S, et al
     Xpert MTB/RIF Ultra-resistant and MTBDRplus-susceptible rifampicin results in people with tuberculosis: utility of FluoroType MTBDR and deep sequencing.
     Antimicrob Agents Chemother. 2025 Feb 7:e0167124. doi: 10.1128/aac.01671.
     

     >> Share

     
     January 2025
165. FORRISTER NM, McCarty TP, Pappas PG
     New Perspectives on Antimicrobial Agents: Rezafungin.
     Antimicrob Agents Chemother. 2025;69:e0064623.
     

     >> Share

     
     
166. LI T, Zhu Y, Xiang G, Xu Z, et al
     Adaptive evolution of extensive drug resistance and persistence in epidemic ST11 KPC-producing Klebsiella pneumoniae during antimicrobial chemotherapy.
     Antimicrob Agents Chemother. 2025;69:e0123524.
     

     >> Share

     
     
167. KOENIG C, Monogue ML, Shields RK, Sakon CM, et al
     Cefiderocol pharmacokinetics during acute pulmonary exacerbations in hospitalized adult persons with cystic fibrosis.
     Antimicrob Agents Chemother. 2025;69:e0153924.
     

     >> Share

     
     
168. HE Z, Huang Y, Li W, Zhang H, et al
     Characterization and genomic analysis of the highly virulent Acinetobacter baumannii ST1791 strain dominating in Anhui, China.
     Antimicrob Agents Chemother. 2025;69:e0126224.
     

     >> Share

     
     
169. MORITA D, Mukhopadhyay AK, Chowdhury G, Maruyama F, et al
     Genomic epidemiology and genetic characteristics of clinical Campylobacter species cocirculating in West Bengal, India, 2019, using whole genome analysis.
     Antimicrob Agents Chemother. 2025;69:e0110824.
     

     >> Share

     
     
170. WANG J, Liu X, Song Y, Liu Z, et al
     LC-AMP-I1, a novel venom-derived antimicrobial peptide from the wolf spider Lycosa coelestis.
     Antimicrob Agents Chemother. 2025;69:e0042424.
     

     >> Share

     
     
171. WIEDERHOLD NP, Patterson HP, Ferrer D, Garcia V, et al
     Olorofim demonstrates in vitro activity against Coccidioides species, including isolates against which fluconazole has reduced activity.
     Antimicrob Agents Chemother. 2025;69:e0098824.
     

     >> Share

     
     
172. ZHU Q, Wijnants S, Feil R, Van Genechten W, et al
     The stress-protectant molecule trehalose mediates fluconazole tolerance in Candida glabrata.
     Antimicrob Agents Chemother. 2025 Jan 24:e0134924. doi: 10.1128/aac.01349.
     

     >> Share

     
     
173. VOGENSEN VB, Singh S, Allende CJ, Engelthaler DM, et al
     Fluoroquinolones and rifampin combination in the backdrop of heteroresistant tuberculosis.
     Antimicrob Agents Chemother. 2025 Jan 16:e0108424. doi: 10.1128/aac.01084.
     

     >> Share

     
     
174. SADER HS, Smart JI, Mendes RE, Castanheira M, et al
     Ceftobiprole activity against multidrug-resistant Staphylococcus aureus clinical isolates collected in the United States from 2016 through 2022.
     Antimicrob Agents Chemother. 2025 Jan 13:e0140224. doi: 10.1128/aac.01402.
     

     >> Share

     
     December 2024
175. JEHANNE Q, Benejat L, Ducournau A, Aptel J, et al
     Increasing rates of erm(B) and erm(N) in human Campylobacter coli and Campylobacter jejuni erythromycin-resistant isolates between 2018 and 2023 in France.
     Antimicrob Agents Chemother. 2024 Dec 31:e0166824. doi: 10.1128/aac.01668.
     

     >> Share

     
     
176. OLLINGER TL, Zarnowski R, Parker JE, Kelly SL, et al
     Genetic interaction analysis of Candida glabrata transcription factors CST6 and UPC2A in the regulation of respiration and fluconazole susceptibility.
     Antimicrob Agents Chemother. 2024 Dec 23:e0129424. doi: 10.1128/aac.01294.
     

     >> Share

     
     
177. ZAGALIOTIS P, Michalik-Provasek J, Mavridou E, Naing E, et al
     Bacteriophage treatment is effective against carbapenem-resistant Klebsiella pneumoniae (KPC) in a neutropenic murine model of gastrointestinal translocation and renal infection.
     Antimicrob Agents Chemother. 2024 Dec 20:e0091924. doi: 10.1128/aac.00919.
     

     >> Share

     
     
178. GHATBALE P, Sah GP, Dunham S, Khong E, et al
     In vitro resensitization of multidrug-resistant clinical isolates of Enterococcus faecium and E. faecalis through phage-antibiotic synergy.
     Antimicrob Agents Chemother. 2024 Dec 19:e0074024. doi: 10.1128/aac.00740.
     

     >> Share

     
     
179. HIRAYAMA T, Miyazaki T, Tanaka R, Kitahori N, et al
     TAC1b mutation in Candida auris decreases manogepix susceptibility owing to increased CDR1 expression.
     Antimicrob Agents Chemother. 2024 Dec 18:e0150824. doi: 10.1128/aac.01508.
     

     >> Share

     
     
180. HEINE HS, Purcell BK, Duncan C, Miller L, et al
     Evaluation of a potent LpxC inhibitor for post-exposure prophylaxis treatment of antibiotic-resistant Burkholderia pseudomallei in a murine infection model.
     Antimicrob Agents Chemother. 2024 Dec 13:e0129524. doi: 10.1128/aac.01295.
     

     >> Share

     
     
181. BLANCO-MARTIN T, Gonzalez-Pinto L, Aja-Macaya P, Rodriguez-Pallares S, et al
     Mutant prevention concentrations, in vitro resistance evolution dynamics, and mechanisms of resistance to imipenem and imipenem/relebactam in carbapenem-susceptible Klebsiella pneumoniae isolates showing ceftazidime/avibactam resistance.
     Antimicrob Agents Chemother. 2024;68:e0112024.
     

     >> Share

     
     
182. LE TM, Eubank TA, McKelvey AM, Cao X, et al
     Fidaxomicin resistance in Clostridioides difficile: a systematic review and predictive modeling with RNA polymerase binding sites.
     Antimicrob Agents Chemother. 2024;68:e0120624.
     

     >> Share

     
     
183. ZHAO H, Hu Y, Nie D, Li N, et al
     A peptide targeting outer membrane protein A of Acinetobacter baumannii exhibits antibacterial activity by reducing bacterial pathogenicity.
     Antimicrob Agents Chemother. 2024;68:e0056524.
     

     >> Share

     
     
184. RODRIGUEZ-PALLARES S, Blanco-Martin T, Lence E, Aja-Macaya P, et al
     In vivo emergence of resistance to ceftazidime/avibactam through modification of chromosomal AmpC beta-lactamase in Klebsiella aerogenes.
     Antimicrob Agents Chemother. 2024;68:e0130724.
     

     >> Share

     
     
185. XU T, Wu W, Huang L, Liu B, et al
     Novel plasmid-mediated CMY variant (CMY-192) conferring ceftazidime-avibactam resistance in multidrug-resistant Escherichia coli.
     Antimicrob Agents Chemother. 2024;68:e0090624.
     

     >> Share

     
     
186. WANG L, Li Y, Xiu L, Hu L, et al
     Multigeographic clinical assessment of a molecular diagnostic assay for detection of key codons to predict decreased susceptibility or resistance to cephalosporins in Neisseria gonorrhoeae.
     Antimicrob Agents Chemother. 2024;68:e0116524.
     

     >> Share

     
     
187. YANG C, Wang L, Lv J, Wen Y, et al
     Effects of different carbapenemase and siderophore production on cefiderocol susceptibility in Klebsiella pneumoniae.
     Antimicrob Agents Chemother. 2024;68:e0101924.
     

     >> Share

     
     
188. ARAGAW WW, Gebresilase TT, Negatu DA, Dartois V, et al
     Multidrug tolerance conferred by loss-of-function mutations in anti-sigma factor RshA of Mycobacterium abscessus.
     Antimicrob Agents Chemother. 2024;68:e0105124.
     

     >> Share

     
     
189. MELENDEZ JH, Edwards VL, Muniz Tirado A, Hardick J, et al
     Local emergence and global evolution of Neisseria gonorrhoeae with high-level resistance to azithromycin.
     Antimicrob Agents Chemother. 2024;68:e0092724.
     

     >> Share

     
     November 2024
190. BUSH NG, Diez-Santos I, Sankara Krishna P, Clavijo B, et al
     Insights into antibiotic resistance promoted by quinolone exposure.
     Antimicrob Agents Chemother. 2024 Nov 26:e0099724. doi: 10.1128/aac.00997.
     

     >> Share

     
     
191. JIA H, Li X, Zhuang Y, Wu Y, et al
     Neural network-based predictions of antimicrobial resistance phenotypes in multidrug-resistant Acinetobacter baumannii from whole genome sequencing and gene expression.
     Antimicrob Agents Chemother. 2024 Nov 14:e0144624. doi: 10.1128/aac.01446.
     

     >> Share

     
     
192. HERRERA C, Gomis-Font MA, Lopez-Causape C, Diez-Aguilar M, et al
     Mechanisms leading to in vivo ceftazidime/avibactam resistance development during treatment of GES-5-producing Pseudomonas aeruginosa infections.
     Antimicrob Agents Chemother. 2024;68:e0116424.
     

     >> Share

     
     
193. BLANCO-MARTIN T, Lopez-Hernandez I, Aracil B, Gonzalez-Pinto L, et al
     Assessment of the activity and mechanisms of resistance to cefiderocol and combinations of beta-lactams and the novel beta-lactamase inhibitors avibactam, taniborbactam, zidebactam, nacubactam, xeruborbactam, and ANT3310 in emerging double-carbapenema
     Antimicrob Agents Chemother. 2024;68:e0092424.
     

     >> Share

     
     
194. SATTLER J, Ernst CM, Zweigner J, Hamprecht A, et al
     High frequency of acquired virulence factors in carbapenemase-producing Klebsiella pneumoniae isolates from a large German university hospital, 2013-2021.
     Antimicrob Agents Chemother. 2024;68:e0060224.
     

     >> Share

     
     
195. PUUMALA E, Nabeela S, Thornburg CC, Grkovic T, et al
     Naamidine A reveals a promising zinc-binding strategy for topical antifungal therapy.
     Antimicrob Agents Chemother. 2024;68:e0119424.
     

     >> Share

     
     
196. SEREME Y, Faury H, Gravrand V, Ageron E, et al
     Molecular insights into the evolutionary trajectory of a Klebsiella aerogenes clinical isolate with a complex trade-off between resistance and virulence.
     Antimicrob Agents Chemother. 2024;68:e0103624.
     

     >> Share

     
     
197. MARTIN MJ, Luo TL, Kovalchuk V, Kondratiuk V, et al
     Detection of cefiderocol and aztreonam/avibactam resistance in epidemic Escherichia coli ST-361 carrying bla(NDM-5) and bla(KPC-3) from foreign fighters evacuated from Ukraine.
     Antimicrob Agents Chemother. 2024;68:e0109024.
     

     >> Share

     
     
198. OKE MT, Martz K, Mocanita M, Knezevic S, et al
     Analysis of Acinetobacter P-type type IV secretion system-encoding plasmid diversity uncovers extensive secretion system conservation and diverse antibiotic resistance determinants.
     Antimicrob Agents Chemother. 2024 Nov 4:e0103824. doi: 10.1128/aac.01038.
     

     >> Share

     
     October 2024
199. KON H, Lurie-Weinberger MN, Bechor M, Temkin E, et al
     bla(GES)-producing ST654 comprises a quarter of all carbapenem-resistant Pseudomonas aeruginosa in blood isolates from 15 hospitals.
     Antimicrob Agents Chemother. 2024 Oct 31:e0096524. doi: 10.1128/aac.00965.
     

     >> Share

     
     
200. LI J, Brandalise D, Coste AT, Sanglard D, et al
     Exploration of novel mechanisms of azole resistance in Candida auris.
     Antimicrob Agents Chemother. 2024 Oct 31:e0126524. doi: 10.1128/aac.01265.
     

     >> Share

     
     
201. MA Z, Zeng W, Liu H, Chen H, et al
     Characterization of novel sequence type 12531 and O8:H7 serotype carbapenem-resistant Escherichia coli with strong swimming and intestinal epithelial cell barrier migration abilities.
     Antimicrob Agents Chemother. 2024 Oct 23:e0080524. doi: 10.1128/aac.00805.
     

     >> Share

     
     
202. ZARSKE M, Werckenthin C, Golz JC, Stingl K, et al
     The point mutation A1387G in the 16S rRNA gene confers aminoglycoside resistance in Campylobacter jejuni and Campylobacter coli.
     Antimicrob Agents Chemother. 2024 Oct 15:e0083324. doi: 10.1128/aac.00833.
     

     >> Share

     
     
203. KENT AG, Spicer LM, Campbell D, Breaker E, et al
     Sentinel Surveillance reveals phylogenetic diversity and detection of linear plasmids harboring vanA and optrA among enterococci collected in the United States.
     Antimicrob Agents Chemother. 2024 Oct 15:e0059124. doi: 10.1128/aac.00591.
     

     >> Share

     
     
204. HONG H, Fan L, Shi W, Zhu Y, et al
     Overexpression of beta-lactamase genes (bla(KPC,) bla(SHV)) and novel CirA deficiencies contribute to decreased cefiderocol susceptibility in carbapenem-resistant Klebsiella pneumoniae before its approval in China.
     Antimicrob Agents Chemother. 2024 Oct 10:e0075424. doi: 10.1128/aac.00754.
     

     >> Share

     
     
205. SALAMA EA, Elgammal Y, Utturkar SM, Lanman NA, et al
     Overcoming amphotericin B resistance in Candida auris using the antiemetic drug rolapitant.
     Antimicrob Agents Chemother. 2024 Oct 10:e0055624. doi: 10.1128/aac.00556.
     

     >> Share

     
     
206. KAUR JN, Klem JF, Liu Y, Boissonneault KR, et al
     Maximally precise combinations to overcome metallo-beta-lactamase-producing Klebsiella pneumoniae.
     Antimicrob Agents Chemother. 2024;68:e0077024.
     

     >> Share

     
     
207. LI H, Oliver A, Shields RK, Kamat S, et al
     Molecular characterization of clinically isolated Pseudomonas aeruginosa with varying resistance to ceftazidime-avibactam and ceftolozane-tazobactam collected as a part of the ATLAS global surveillance program from 2020 to 2021.
     Antimicrob Agents Chemother. 2024;68:e0067024.
     

     >> Share

     
     
208. STURARO MC, Damaceno NdS, Faccin ID, Silva ON, et al
     Synergistic antimicrobial combination of third-generation cephalosporins and polymyxin B against carbapenem-polymyxin-resistant Klebsiella pneumoniae: an in vitro and in vivo analysis.
     Antimicrob Agents Chemother. 2024;68:e0093024.
     

     >> Share

     
     
209. HUANG H, Yang H, Feng S, Zhang X, et al
     High salt condition alters LPS synthesis and induces the emergence of drug resistance mutations in Helicobacter pylori.
     Antimicrob Agents Chemother. 2024;68:e0058724.
     

     >> Share

     
     
210. RUBIO J, Yan J, Miller S, Cheng J, et al
     Polymyxins retain in vitro activity and in vivo efficacy against "resistant" Acinetobacter baumannii strains when tested in physiological conditions.
     Antimicrob Agents Chemother. 2024;68:e0072524.
     

     >> Share

     
     
211. SINGH V, Nandanwar H
     IMT-P8 potentiates Gram-positive specific antibiotics in intrinsically resistant Gram-negative bacteria.
     Antimicrob Agents Chemother. 2024;68:e0075324.
     

     >> Share

     
     
212. HAREZA DA, Cosgrove SE, Bonomo RA, Dzintars K, et al
     Clinical outcomes and emergence of resistance of Pseudomonas aeruginosa infections treated with ceftolozane-tazobactam versus ceftazidime-avibactam.
     Antimicrob Agents Chemother. 2024;68:e0090724.
     

     >> Share

     
     
213. WOOD GE, Lee JW, Peramuna T, Wendt KL, et al
     The fungal natural product fusidic acid demonstrates potent activity against Mycoplasma genitalium.
     Antimicrob Agents Chemother. 2024;68:e0100624.
     

     >> Share

     
     
214. GAONA M, Corral J, Campoy S, Barbe J, et al
     The novel MFS efflux pump SxtP, regulated by the LysR-type transcriptional activator SxtR, is involved in the susceptibility to sulfamethoxazole/trimethoprim (SXT) and the pathogenesis of Acinetobacter baumannii.
     Antimicrob Agents Chemother. 2024;68:e0071224.
     

     >> Share

     
     
215. KOLLER BH, Jania LA, Li H, Barker WT, et al
     Adjuvants restore colistin sensitivity in mouse models of highly colistin-resistant isolates, limiting bacterial proliferation and dissemination.
     Antimicrob Agents Chemother. 2024;68:e0067124.
     

     >> Share

     
     
216. ALLAIN M, Morel-Journel T, Condamine B, Gibeaux B, et al
     IncC plasmid genome rearrangements influence the vertical and horizontal transmission tradeoff in Escherichia coli.
     Antimicrob Agents Chemother. 2024;68:e0055424.
     

     >> Share

     
     
217. DUBEY V, Farrington N, Harper N, Johnson A, et al
     Acinetobacter baumannii transformants expressing oxacillinases and metallo-beta-lactamases that confer resistance to meropenem: new tools for anti-Acinetobacter drug development and AMR preparedness.
     Antimicrob Agents Chemother. 2024;68:e0022224.
     

     >> Share

     
     
218. XU J-Y, Dong H-h, Liao L-j, Yang S-x, et al
     Deoxyshikonin: a promising lead drug grass against drug resistance or sensitivity to Helicobacter pylori in an acidic environment.
     Antimicrob Agents Chemother. 2024;68:e0095924.
     

     >> Share

     
     
219. YASMIN M, Marshall SH, Chen L, Rhoads DD, et al
     A molecular analysis of meropenem-vaborbactam non-susceptible KPC-producing Klebsiella pneumoniae.
     Antimicrob Agents Chemother. 2024;68:e0020824.
     

     >> Share

     
     
220. FUKUSHIMA K, Matsumoto Y, Abe Y, Hashimoto K, et al
     Variability of macrolide-resistant profile in Mycobacterium avium complex pulmonary disease.
     Antimicrob Agents Chemother. 2024 Oct 8:e0121324. doi: 10.1128/aac.01213.
     

     >> Share

     
     September 2024
221. RHODES J, Jacobs J, Dennis EK, Manjari SR, et al
     What makes Candida auris pan-drug resistant? Integrative insights from genomic, transcriptomic, and phenomic analysis of clinical strains resistant to all four major classes of antifungal drugs.
     Antimicrob Agents Chemother. 2024 Sep 19:e0091124. doi: 10.1128/aac.00911.
     

     >> Share

     
     
222. CASTANHEIRA M, Deshpande LM, Rhomberg PR, Carvalhaes CG, et al
     Recent increase in Candida auris frequency in the SENTRY surveillance program: antifungal activity and genotypic characterization.
     Antimicrob Agents Chemother. 2024 Sep 12:e0057024. doi: 10.1128/aac.00570.
     

     >> Share

     
     
223. LE RUN E, Tettelin H, Holland SM, Zelazny AM, et al
     Evolution toward extremely high imipenem resistance in Mycobacterium abscessus outbreak strains.
     Antimicrob Agents Chemother. 2024 Sep 10:e0067324. doi: 10.1128/aac.00673.
     

     >> Share

     
     
224. KOMORI K, Aoki K, Harada S, Ishii Y, et al
     Plasmid-mediated acquisition and chromosomal integration of bla(CTX-M-14) in a subclade of Escherichia coli ST131-H30 clade C1.
     Antimicrob Agents Chemother. 2024;68:e0081724.
     

     >> Share

     
     
225. XUE J, Li S, Wang L, Zhao Y, et al
     Enhanced fatty acid biosynthesis by Sigma28 in stringent responses contributes to multidrug resistance and biofilm formation in Helicobacter pylori.
     Antimicrob Agents Chemother. 2024;68:e0085024.
     

     >> Share

     
     August 2024
226. MARTINI MC, Alonso MN, Cafiero JH, Xiao J, et al
     Loss of glycerol catabolism confers carbon-source-dependent artemisinin resistance in Mycobacterium tuberculosis.
     Antimicrob Agents Chemother. 2024 Aug 28:e0064524. doi: 10.1128/aac.00645.
     

     >> Share

     
     
227. TIAN P, Li Q-Q, Guo M-J, Zhu Y-Z, et al
     Zidovudine in synergistic combination with nitrofurantoin or omadacycline: in vitro and in murine urinary tract or lung infection evaluation against multidrug-resistant Klebsiella pneumoniae.
     Antimicrob Agents Chemother. 2024 Aug 28:e0034424. doi: 10.1128/aac.00344.
     

     >> Share

     
     
228. TAO L, Dahlquist A, Harris H, Jacobs E, et al
     Multicenter evaluation of activity of aztreonam in combination with avibactam, relebactam, and vaborbactam against metallo-beta-lactamase-producing carbapenem-resistant gram-negative bacilli.
     Antimicrob Agents Chemother. 2024 Aug 19:e0069324. doi: 10.1128/aac.00693.
     

     >> Share

     
     
229. HEINE HS, Drusano G, Purcell BK, Anastasiou D, et al
     Omadacycline is active in vitro and in vivo against ciprofloxacin-resistant Bacillus anthracis.
     Antimicrob Agents Chemother. 2024 Aug 12:e0059524. doi: 10.1128/aac.00595.
     

     >> Share

     
     
230. JACOBS MR, Abdelhamed AM, Good CE, Mack AR, et al
     ARGONAUT-III and -V: susceptibility of carbapenem-resistant Klebsiella pneumoniae and multidrug-resistant Pseudomonas aeruginosa to the bicyclic boronate beta-lactamase inhibitor taniborbactam combined with cefepime.
     Antimicrob Agents Chemother. 2024 Aug 12:e0075124. doi: 10.1128/aac.00751.
     

     >> Share

     
     
231. ROTONDO CM, Wright GD
     Efficacy of aspergillomarasmine A/meropenem combinations with and without avibactam against bacterial strains producing multiple beta-lactamases.
     Antimicrob Agents Chemother. 2024 Aug 12:e0027224. doi: 10.1128/aac.00272.
     

     >> Share

     
     
232. EISHA S, Morris AJ, Martin I, Yau YCW, et al
     Effect of L-arginine on cystic fibrosis Pseudomonas aeruginosa biofilms.
     Antimicrob Agents Chemother. 2024;68:e0033624.
     

     >> Share

     
     
233. EGGE SL, Rizvi SA, Simar SR, Alcalde M, et al
     Cefiderocol heteroresistance associated with mutations in TonB-dependent receptor genes in Pseudomonas aeruginosa of clinical origin.
     Antimicrob Agents Chemother. 2024;68:e0012724.
     

     >> Share

     
     
234. PONTA G, Morena V, Strano M, Molteni C, et al
     Safety of rezafungin as a long-term treatment option in two patients with complicated fungal infections: two cases from Lecco Hospital (Italy).
     Antimicrob Agents Chemother. 2024;68:e0075024.
     

     >> Share

     
     July 2024
235. NELSON ME, Little JL, Kristich CJ
     Pbp4 provides transpeptidase activity to the FtsW-PbpB peptidoglycan synthase to drive cephalosporin resistance in Enterococcus faecalis.
     Antimicrob Agents Chemother. 2024 Jul 26:e0055524. doi: 10.1128/aac.00555.
     

     >> Share

     
     
236. ADELMAN MW, Andes DR
     Case Commentary: Extending our therapeutic range against multidrug-resistant Candida.
     Antimicrob Agents Chemother. 2024 Jul 22:e0084724. doi: 10.1128/aac.00847.
     

     >> Share

     
     
237. TRUONG-BOLDUC QC, Wang Y, Lawton BG, Brown Harding H, et al
     Phenazine-1 carboxylic acid of Pseudomonas aeruginosa induces the expression of Staphylococcus aureus Tet38 MDR efflux pump and mediates resistance to phenazines and antibiotics.
     Antimicrob Agents Chemother. 2024 Jul 19:e0063624. doi: 10.1128/aac.00636.
     

     >> Share

     
     
238. GIGANTE V, Alm RA, Melchiorri D, Rocke T, et al
     Multi-year analysis of the global preclinical antibacterial pipeline: trends and gaps.
     Antimicrob Agents Chemother. 2024 Jul 15:e0053524. doi: 10.1128/aac.00535.
     

     >> Share

     
     
239. STRAHILEVITZ J, Motro Y, Temper V, Merezhko D, et al
     In vivo selection of carbapenem resistance during persistent Klebsiella pneumoniae sequence type 395 bloodstream infection due to OmpK36 deletion.
     Antimicrob Agents Chemother. 2024 Jul 11:e0066324. doi: 10.1128/aac.00663.
     

     >> Share

     
     
240. DULYAYANGKUL P, Sealey JE, Lee WWY, Satapoomin N, et al
     Improving nitrofurantoin resistance prediction in Escherichia coli from whole-genome sequence by integrating NfsA/B enzyme assays.
     Antimicrob Agents Chemother. 2024;68:e0024224.
     

     >> Share

     
     
241. BEREDAKI M-I, Arendrup MC, Pournaras S, Meletiadis J, et al
     Comparative pharmacodynamics and dose optimization of liposomal amphotericin B against Candida species in an in vitro pharmacokinetic/pharmacodynamic model.
     Antimicrob Agents Chemother. 2024 Jul 3:e0022524. doi: 10.1128/aac.00225.
     

     >> Share

     
     June 2024
242. MA Y, Pirolo M, Jana B, Mebus VH, et al
     The intrinsic macrolide resistome of Escherichia coli.
     Antimicrob Agents Chemother. 2024 Jun 28:e0045224. doi: 10.1128/aac.00452.
     

     >> Share

     
     
243. KURTZHALS ML, Norman A, Svensson E, Lillebaek T, et al
     Applying whole genome sequencing to predict phenotypic drug resistance in Mycobacterium tuberculosis: leveraging 20 years of nationwide data from Denmark.
     Antimicrob Agents Chemother. 2024 Jun 21:e0043024. doi: 10.1128/aac.00430.
     

     >> Share

     
     
244. PLUMET L, Magnan C, Ahmad-Mansour N, Sotto A, et al
     The zebrafish embryo model: unveiling its potential for investigating phage therapy against methicillin-resistant Staphylococcus aureus infection.
     Antimicrob Agents Chemother. 2024 Jun 20:e0056124. doi: 10.1128/aac.00561.
     

     >> Share

     
     
245. SON JE, Park SH, Choi U, Lee C-R, et al
     Lytic transglycosylase repertoire diversity enables intrinsic antibiotic resistance and daughter cell separation in Escherichia coli under acidic stress.
     Antimicrob Agents Chemother. 2024 Jun 17:e0037224. doi: 10.1128/aac.00372.
     

     >> Share

     
     
246. DIAMOND TL, Goh SL, Ngo W, Rodriguez S, et al
     No antagonism or cross-resistance and a high barrier to the emergence of resistance in vitro for the combination of islatravir and lenacapavir.
     Antimicrob Agents Chemother. 2024 Jun 12:e0033424. doi: 10.1128/aac.00334.
     

     >> Share

     
     
247. PETERSIEL N, Giulieri S, Daniel DS, Fan S-H, et al
     Genomic investigation and clinical correlates of the in vitro beta-lactam: NaHCO(3) responsiveness phenotype among methicillin-resistant Staphylococcus aureus isolates from a randomized clinical trial.
     Antimicrob Agents Chemother. 2024 Jun 5:e0021824. doi: 10.1128/aac.00218.
     

     >> Share

     
     
248. MINUK LM, Brode SK, Mehrabi M, Sharma MK, et al
     Phenotypic amikacin resistance may not indicate poor response to amikacin in Mycobacterium avium complex pulmonary disease.
     Antimicrob Agents Chemother. 2024;68:e0008424.
     

     >> Share

     
     May 2024
249. HUANG E, Thompson RN, Moon SH, Keck JM, et al
     Treatment-emergent cefiderocol resistance in carbapenem-resistant Acinetobacter baumannii is associated with insertion sequence ISAba36 in the siderophore receptor pirA.
     Antimicrob Agents Chemother. 2024 May 29:e0029024. doi: 10.1128/aac.00290.
     

     >> Share

     
     
250. ANOY MMI, Kim W-J, Gelston S, Fleming D, et al
     Evaluation of treatment of methicillin-resistant Staphylococcus aureus biofilms with intermittent electrochemically generated H(2)O(2) or HOCl.
     Antimicrob Agents Chemother. 2024 May 21:e0172223. doi: 10.1128/aac.01722.
     

     >> Share

     
     
251. LUO J, Liu M, Ai W, Zheng X, et al
     Synergy of lytic phage pB23 and meropenem combination against carbapenem-resistant Acinetobacter baumannii.
     Antimicrob Agents Chemother. 2024 May 14:e0044824. doi: 10.1128/aac.00448.
     

     >> Share

     
     
252. BERGIN S, Doorley LA, Rybak JM, Wolfe KH, et al
     Analysis of clinical Candida parapsilosis isolates reveals copy number variation in key fluconazole resistance genes.
     Antimicrob Agents Chemother. 2024 May 7:e0161923. doi: 10.1128/aac.01619.
     

     >> Share

     
     
253. TAKEMOTO K, Nakayama R, Fujimoto K, Suzuki Y, et al
     In vitro and in vivo activities of KSP-1007, a broad-spectrum inhibitor of serine- and metallo-beta-lactamases, in combination with meropenem against carbapenem-resistant Gram-negative bacteria.
     Antimicrob Agents Chemother. 2024 May 6:e0160223. doi: 10.1128/aac.01602.
     

     >> Share

     
     
254. SCHALKWIJK HH, Shewakramani NR, Das K, Andrei G, et al
     Combination of ganciclovir and trifluridine prevents drug-resistance emergence in HSV-1.
     Antimicrob Agents Chemother. 2024;68:e0011024.
     

     >> Share

     
     
255. VEGA AD, DeRonde K, Jimenez A, Piazza M, et al
     Difficult-to-treat (DTR) Pseudomonas aeruginosa harboring Verona-Integron metallo-beta-lactamase (bla(VIM)): infection management and molecular analysis.
     Antimicrob Agents Chemother. 2024;68:e0147423.
     

     >> Share

     
     
256. MILLER AA, Moussa SH, McLeod SM
     Characterization of Acinetobacter baumannii-calcoaceticus complex isolates and microbiological outcome for patients treated with sulbactam-durlobactam in a phase 3 trial (ATTACK).
     Antimicrob Agents Chemother. 2024;68:e0169823.
     

     >> Share

     
     
257. ISHII M, Yamada T, Ishikawa K, Ichinose K, et al
     The Ptk2-Pma1 pathway enhances tolerance to terbinafine in Trichophyton rubrum.
     Antimicrob Agents Chemother. 2024;68:e0160923.
     

     >> Share

     
     
258. GHOSH S, Orman MA
     Exploring the links between SOS response, mutagenesis, and resistance during the recovery period.
     Antimicrob Agents Chemother. 2024;68:e0146223.
     

     >> Share

     
     
259. CASTANHEIRA M, Kimbrough JH, Lindley J, Doyle TB, et al
     In vitro development of resistance against antipseudomonal agents: comparison of novel beta-lactam/beta-lactamase inhibitor combinations and other beta-lactam agents.
     Antimicrob Agents Chemother. 2024;68:e0136323.
     

     >> Share

     
     
260. XIA L, Li Y, Wang Y, Zhou H, et al
     Quorum-sensing regulation of phenazine production heightens Pseudomonas aeruginosa resistance to ciprofloxacin.
     Antimicrob Agents Chemother. 2024;68:e0011824.
     

     >> Share

     
     
261. SUZUKI D, Sakurai A, Wakuda M, Suzuki M, et al
     Clinical and genomic characteristics of IMP-producing Enterobacter cloacae complex and Klebsiella pneumoniae.
     Antimicrob Agents Chemother. 2024;68:e0167223.
     

     >> Share

     
     
262. NIELSEN TK, Petersen IB, Xu L, Barbuti MD, et al
     The Spx stress regulator confers high-level beta-lactam resistance and decreases susceptibility to last-line antibiotics in methicillin-resistant Staphylococcus aureus.
     Antimicrob Agents Chemother. 2024 May 1:e0033524. doi: 10.1128/aac.00335.
     

     >> Share

     
     April 2024
263. PETRAITIS V, Petraitiene R, Kavaliauskas P, Naing E, et al
     Development of rabbit models of ventilator-associated bacterial pneumonia produced by carbapenem-resistant Pseudomonas aeruginosa.
     Antimicrob Agents Chemother. 2024 Apr 30:e0020524. doi: 10.1128/aac.00205.
     

     >> Share

     
     
264. SHAFER WM, Conn GL
     Ensuring a sustained workforce to combat antibiotic resistance in the 21st century: the critical need for training the next-gen of scientists at the pre-doctoral level.
     Antimicrob Agents Chemother. 2024 Apr 19:e0024424. doi: 10.1128/aac.00244.
     

     >> Share

     
     
265. LYU Z, Ling Y, van Hoof A, Ling J, et al
     Inactivation of the ribosome assembly factor RimP causes streptomycin resistance and impairs motility in Salmonella.
     Antimicrob Agents Chemother. 2024 Apr 17:e0000224. doi: 10.1128/aac.00002.
     

     >> Share

     
     
266. HARTUIS S, Ourliac-Garnier I, Robert E, Albassier M, et al
     Precise genome editing underlines the distinct contributions of mutations in ERG11, ERG3, MRR1, and TAC1 genes to antifungal resistance in Candida parapsilosis.
     Antimicrob Agents Chemother. 2024 Apr 16:e0002224. doi: 10.1128/aac.00022.
     

     >> Share

     
     
267. LOSSOUARN J, Beurrier E, Bouteau A, Moncaut E, et al
     The virtue of training: extending phage host spectra against vancomycin-resistant Enterococcus faecium strains using the Appelmans method.
     Antimicrob Agents Chemother. 2024 Apr 9:e0143923. doi: 10.1128/aac.01439.
     

     >> Share

     
     
268. TENG T, Chen S, Huo F, Jia J, et al
     Efflux pump effects on levofloxacin resistance in Mycobacterium abscessus.
     Antimicrob Agents Chemother. 2024 Apr 4:e0134823. doi: 10.1128/aac.01348.
     

     >> Share

     
     
269. SHANG Y, Zhang Y, Wang R, Peng Y, et al
     Deciphering the molecular and functional basis of TMexCD1: the plasmid-encoded efflux pump of resistance-nodulation-division superfamily.
     Antimicrob Agents Chemother. 2024;68:e0167823.
     

     >> Share

     
     
270. RIBEIRO DOS SANTOS A, Gade L, Misas E, Litvintseva AP, et al
     Bimodal distribution of azole susceptibility in Sporothrix brasiliensis isolates in Brazil.
     Antimicrob Agents Chemother. 2024;68:e0162023.
     

     >> Share

     
     
271. TAIT JR, Anderson D, Nation RL, Creek DJ, et al
     Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa.
     Antimicrob Agents Chemother. 2024;68:e0108123.
     

     >> Share

     
     
272. YANO H, Hayashi W, Kawakami S, Aoki S, et al
     Nationwide genome surveillance of carbapenem-resistant Pseudomonas aeruginosa in Japan.
     Antimicrob Agents Chemother. 2024 Apr 2:e0166923. doi: 10.1128/aac.01669.
     

     >> Share

     
     March 2024
273. MAIA AR, Cezard A, Fouquenet D, Vasseur V, et al
     Preventive nasal administration of flagellin restores antimicrobial effect of gentamicin and protects against a multidrug-resistant strain of Pseudomonas aeruginosa.
     Antimicrob Agents Chemother. 2024 Mar 25:e0136123. doi: 10.1128/aac.01361.
     

     >> Share

     
     
274. SEGAWA T, Masuda K, Hisatsune J, Ishida-Kuroki K, et al
     Genomic analysis of inter-hospital transmission of vancomycin-resistant Enterococcus faecium sequence type 80 isolated during an outbreak in Hiroshima, Japan.
     Antimicrob Agents Chemother. 2024 Mar 20:e0171623. doi: 10.1128/aac.01716.
     

     >> Share

     
     
275. SUN L, Zhuang H, Chen M, Chen Y, et al
     Vancomycin heteroresistance caused by unstable tandem amplifications of the vanM gene cluster on linear conjugative plasmids in a clinical Enterococcus faecium.
     Antimicrob Agents Chemother. 2024 Mar 20:e0115923. doi: 10.1128/aac.01159.
     

     >> Share

     
     
276. LI W, He Z, Di W, Xu W, et al
     Transposition mechanism of ISApl1-the determinant of colistin resistance dissemination.
     Antimicrob Agents Chemother. 2024;68:e0123123.
     

     >> Share

     
     
277. ANDRE C, Van Camp AG, Ung L, Gilmore MS, et al
     Characterization of the resistome and predominant genetic lineages of Gram-positive bacteria causing keratitis.
     Antimicrob Agents Chemother. 2024;68:e0124723.
     

     >> Share

     
     
278. CARUSO L, Mellini M, Catalano Gonzaga O, Astegno A, et al
     Hydrogen sulfide production does not affect antibiotic resistance in Pseudomonas aeruginosa.
     Antimicrob Agents Chemother. 2024 Mar 6:e0007524. doi: 10.1128/aac.00075.
     

     >> Share

     
     February 2024
279. ZHANG M, Yang B, Shi J, Wang Z, et al
     Host defense peptides mitigate the spread of antibiotic resistance in physiologically relevant condition.
     Antimicrob Agents Chemother. 2024 Feb 28:e0126123. doi: 10.1128/aac.01261.
     

     >> Share

     
     
280. MULATO A, Lansdon E, Aoyama R, Voigt J, et al
     Preclinical characterization of a non-peptidomimetic HIV protease inhibitor with improved metabolic stability.
     Antimicrob Agents Chemother. 2024 Feb 21:e0137323. doi: 10.1128/aac.01373.
     

     >> Share

     
     
281. FREIBERG JA, Tao L, Manuel C, Mike LA, et al
     A multi-species outbreak of VIM-producing carbapenem-resistant bacteria in a burn unit and subsequent investigation of rapid development of cefiderocol resistance.
     Antimicrob Agents Chemother. 2024 Feb 20:e0150723. doi: 10.1128/aac.01507.
     

     >> Share

     
     
282. BASSERES E, Eubank TA, Begum K, Alam MJ, et al
     Antibacterial activity of ibezapolstat against antimicrobial-resistant clinical strains of Clostridioides difficile.
     Antimicrob Agents Chemother. 2024 Feb 16:e0162123. doi: 10.1128/aac.01621.
     

     >> Share

     
     
283. ERSOY SC, Proctor RA, Rose WE, Abdelhady W, et al
     Sensitizing methicillin-resistant Staphylococcus aureus (MRSA) to cefuroxime: the synergic effect of bicarbonate and the wall teichoic acid inhibitor ticlopidine.
     Antimicrob Agents Chemother. 2024 Feb 13:e0162723. doi: 10.1128/aac.01627.
     

     >> Share

     
     
284. PITOUT JDD, Peirano G, Matsumura Y, DeVinney R, et al
     Escherichia coli sequence type 410 with carbapenemases: a paradigm shift within E. coli toward multidrug resistance.
     Antimicrob Agents Chemother. 2024;68:e0133923.
     

     >> Share

     
     
285. DRUSIN SI, Le Terrier C, Poirel L, Bonomo RA, et al
     Structural basis of metallo-beta-lactamase resistance to taniborbactam.
     Antimicrob Agents Chemother. 2024;68:e0116823.
     

     >> Share

     
     January 2024
286. JIANG X, Li D, Sun Z, Lu Y, et al
     Type I BREX system defends against antibiotic-resistant plasmids in Escherichia coli.
     Antimicrob Agents Chemother. 2024 Jan 30:e0112823. doi: 10.1128/aac.01128.
     

     >> Share

     
     
287. IOVLEVA A, McElheny CL, Fowler EL, Cober E, et al
     In vitro activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant Acinetobacter baumannii collected in U.S. hospitals.
     Antimicrob Agents Chemother. 2024 Jan 30:e0125823. doi: 10.1128/aac.01258.
     

     >> Share

     
     
288. ZALACAIN M, Achard P, Llanos A, Morrissey I, et al
     Meropenem-ANT3310, a unique beta-lactam-beta-lactamase inhibitor combination with expanded antibacterial spectrum against Gram-negative pathogens including carbapenem-resistant Acinetobacter baumannii.
     Antimicrob Agents Chemother. 2024 Jan 30:e0112023. doi: 10.1128/aac.01120.
     

     >> Share

     
     
289. AXELL-HOUSE DB, Simar SR, Panesso D, Rincon S, et al
     LiaX is a surrogate marker for cell envelope stress and daptomycin non-susceptibility in Enterococcus faecium.
     Antimicrob Agents Chemother. 2024 Jan 30:e0106923. doi: 10.1128/aac.01069.
     

     >> Share

     
     
290. ALDEJOHANN AM, Menner C, Thielemann N, Martin R, et al
     In vitro activity of ibrexafungerp against clinically relevant echinocandin-resistant Candida strains.
     Antimicrob Agents Chemother. 2024 Jan 11:e0132423. doi: 10.1128/aac.01324.
     

     >> Share

     
     
291. TERAN N, Egge SL, Phe K, Baptista RP, et al
     The emergence of cefiderocol resistance in Pseudomonas aeruginosa from a heteroresistant isolate during prolonged therapy.
     Antimicrob Agents Chemother. 2024;68:e0100923.
     

     >> Share

     
     
292. CHEN T, Yao J, Quan K, Xu J, et al
     Repurposing a human acetyl-CoA carboxylase inhibitor firsocostat to treat fungal candidiasis alone and in combination.
     Antimicrob Agents Chemother. 2024;68:e0113123.
     

     >> Share

     
     December 2023
293. TAKEMURA M, Nakamura R, Ota M, Nakai R, et al
     In vitro and in vivo activity of cefiderocol against Achromobacter spp. and Burkholderia cepacia complex, including carbapenem-non-susceptible isolates.
     Antimicrob Agents Chemother. 2023;67:e0034623.
     

     >> Share

     
     November 2023
294. ZHAO J, Pu D, Li Z, Liu X, et al
     In vitro activity of cefiderocol, a siderophore cephalosporin, against carbapenem-resistant hypervirulent Klebsiella pneumoniae in China.
     Antimicrob Agents Chemother. 2023 Nov 28:e0073523. doi: 10.1128/aac.00735.
     

     >> Share

     
     
295. JIAO F, Bao Y, Li M, Zhang Y, et al
     Unraveling the mechanism of ceftaroline-induced allosteric regulation in penicillin-binding protein 2a: insights for novel antibiotic development against methicillin-resistant Staphylococcus aureus.
     Antimicrob Agents Chemother. 2023 Nov 16:e0089523. doi: 10.1128/aac.00895.
     

     >> Share

     
     
296. DIAZ-GARCIA J, Machado M, Alcala L, Reigadas E, et al
     Trends in antifungal resistance in Candida from a multicenter study conducted in Madrid (CANDIMAD study): fluconazole-resistant C. parapsilosis spreading has gained traction in 2022.
     Antimicrob Agents Chemother. 2023;67:e0098623.
     

     >> Share

     
     
297. BOSCH A, Macha ME, Ren Q, Kohler P, et al
     Resistance development in Escherichia coli to delafloxacin at pHs 6.0 and 7.3 compared to ciprofloxacin.
     Antimicrob Agents Chemother. 2023;67:e0162522.
     

     >> Share

     
     
298. SCHILDKRAUT JA, Raaijmakers J, Aarnoutse R, Hoefsloot W, et al
     The role of rifampicin within the treatment of Mycobacterium avium pulmonary disease.
     Antimicrob Agents Chemother. 2023;67:e0087423.
     

     >> Share

     
     
299. YAMADA T, Maeda M, Nagai H, Salamin K, et al
     Two different types of tandem sequences mediate the overexpression of TinCYP51B in azole-resistant Trichophyton indotineae.
     Antimicrob Agents Chemother. 2023;67:e0093323.
     

     >> Share

     
     October 2023
300. JIANG S, Chen M, Zhang J, Ba X, et al
     Profiling daptomycin resistance among diverse methicillin-resistant Staphylococcus aureus lineages in China.
     Antimicrob Agents Chemother. 2023 Oct 30:e0056323. doi: 10.1128/aac.00563.
     

     >> Share

     
     
301. ZHANG S-P, Ye Y-P, Hou J, Ye Z-R, et al
     Antitoxin MqsA decreases antibiotic susceptibility through the global regulator AgtR in Pseudomonas fluorescens.
     Antimicrob Agents Chemother. 2023 Oct 25:e0081223. doi: 10.1128/aac.00812.
     

     >> Share

     
     
302. TAKAHASHI H, Morita M, Kamiya H, Fukusumi M, et al
     Emergence of ciprofloxacin- and penicillin-resistant Neisseria meningitidis isolates in Japan between 2003 and 2020 and its genetic features.
     Antimicrob Agents Chemother. 2023 Oct 24:e0074423. doi: 10.1128/aac.00744.
     

     >> Share

     
     
303. LAU JZ, Kuo SH, Belo Y, Malach E, et al
     Antibacterial efficacy of an ultra-short palmitoylated random peptide mixture in mouse models of infection by carbapenem-resistant Klebsiella pneumoniae.
     Antimicrob Agents Chemother. 2023 Oct 11:e0057423. doi: 10.1128/aac.00574.
     

     >> Share

     
     
304. KUHBACHER A, Merschak P, Haas H, Liebl M, et al
     The cytochrome P450 reductase CprA is a rate-limiting factor for Cyp51A-mediated azole resistance in Aspergillus fumigatus.
     Antimicrob Agents Chemother. 2023 Oct 10:e0091823. doi: 10.1128/aac.00918.
     

     >> Share

     
     
305. LOMOVSKAYA O, Castanheira M, Lindley J, Rubio-Aparicio D, et al
     In vitro potency of xeruborbactam in combination with multiple beta-lactam antibiotics in comparison with other beta-lactam/beta-lactamase inhibitor (BLI) combinations against carbapenem-resistant and extended-spectrum beta-lactamase-producing Enterob
     Antimicrob Agents Chemother. 2023 Oct 6:e0044023. doi: 10.1128/aac.00440.
     

     >> Share

     
     September 2023
306. MIRON-OCAMPO A, Beattie SR, Guin S, Conway T, et al
     CWHM-974 is a fluphenazine derivative with improved antifungal activity against Candida albicans due to reduced susceptibility to multidrug transporter-mediated resistance mechanisms.
     Antimicrob Agents Chemother. 2023 Sep 13:e0056723. doi: 10.1128/aac.00567.
     

     >> Share

     
     
307. PODOLL JD, Rosen E, Wang W, Gao Y, et al
     A small-molecule membrane fluidizer re-sensitizes methicillin-resistant Staphylococcus aureus (MRSA) to beta-lactam antibiotics.
     Antimicrob Agents Chemother. 2023 Sep 8:e0005123. doi: 10.1128/aac.00051.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share